Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- Check6 days agoChange DetectedNew entries for Contacts/Locations and Study Status were added in the record history (dated 2025-12-04 and 2025-12-03). A deletion was recorded on 2025-10-09.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision history shows a new entry 'Revision: v3.3.2' added and 'Revision: v3.2.0' removed; this is a minor metadata update to the page history and does not affect core study information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the site-wide government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check42 days agoChange DetectedThe new screenshot shows a redesigned header and layout on the Record History page, while the version history list and study details remain the same.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a new study status/contacts section and a current date entry; removed an older date reference. Focus shifts to current information and contacts.SummaryDifference1%

- Check71 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference12%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.